China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50,724 | 23,953 | 76,861 | 64,838 | 44,890 |
| Depreciation Amortization | 3,661 | 1,649 | 7,462 | 5,578 | 3,808 |
| Income taxes - deferred | 1,155 | 920 | 113 | 428 | 721 |
| Accounts receivable | -7,474 | -6,392 | -5,667 | -10,758 | -6,315 |
| Accounts payable and accrued liabilities | -438 | -1,386 | 1,622 | 1,254 | 242 |
| Other Working Capital | -15,926 | -15,668 | -12,986 | -14,978 | -13,754 |
| Other Operating Activity | 7,325 | 8,439 | 6,899 | 12,097 | 8,316 |
| Operating Cash Flow | $39,027 | $11,515 | $74,303 | $58,460 | $37,909 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,609 | 6,609 | N/A | N/A | N/A |
| PPE Investments | -10,053 | -6,211 | -20,297 | -16,901 | -11,829 |
| Purchase Of Investment | N/A | N/A | -6,609 | N/A | N/A |
| Purchase Sale Intangibles | -1,228 | -1,083 | -1,327 | -1,141 | -1,138 |
| Other Investing Activity | 407 | 552 | 1,338 | -580 | -577 |
| Investing Cash Flow | $-3,037 | $950 | $-25,568 | $-17,481 | $-12,406 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 9,693 | 4,808 | 4,808 |
| Debt Issued | 70,000 | 70,000 | 30,000 | 30,000 | N/A |
| Debt Repayment | N/A | -72,129 | N/A | -30,000 | N/A |
| Common Stock Issued | 1,644 | 206 | 5,394 | 3,035 | 2,669 |
| Common Stock Repurchased | -70,000 | -70,000 | -29,594 | -29,594 | N/A |
| Dividend Paid | -1,410 | -1,410 | -16,931 | -10,897 | -8,110 |
| Other Financing Activity | -76,436 | -4,906 | -37,087 | -9,978 | -9,978 |
| Financing Cash Flow | $-76,202 | $-78,238 | $-38,525 | $-42,625 | $-10,611 |
| Exchange Rate Effect | -704 | -817 | 4,318 | 3,534 | 2,763 |
| Beginning Cash Position | 144,139 | 144,139 | 129,609 | 129,609 | 129,609 |
| End Cash Position | 103,224 | 77,548 | 144,139 | 131,497 | 147,265 |
| Net Cash Flow | $-40,915 | $-66,590 | $14,529 | $1,887 | $17,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,027 | 11,515 | 74,303 | 58,460 | 37,909 |
| Capital Expenditure | -10,243 | -6,386 | -20,492 | -17,077 | -11,913 |
| Free Cash Flow | 28,784 | 5,130 | 53,811 | 41,384 | 25,996 |